• OPEN AN ACCOUNT
Indian Indices
Sensex
74,459.53 308.49
( 0.42%)
Global Indices
Nasdaq
51,732.40 -631.16
(-1.21%)
Dow Jones
7,581.68 -159.71
(-2.06%)
Hang Seng
63,176.05 -1,483.42
(-2.29%)
Nikkei 225
10,722.51 0.44
(0.00%)
Forex
USD-INR
95.22 0.06
(0.06%)
EUR-INR
106.19 0.24
(0.23%)
GBP-INR
127.01 0.44
(0.35%)
JPY-INR
0.60 0.00
(0.12%)

EQUITY - MARKET SCREENER

Caplin Point Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524742
INE475E01026
269.7614245
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CAPLIPOINT
42.1
17671.58
EPS(TTM)
Face Value()
Div & Yield %
55.22
2
0.34
 

Sanmit Infra standalone net profit rises 3.77% in the March 2026 quarter
May 29,2026
Net profit of Sanmit Infra rose 3.77% to Rs 1.65 crore in the quarter ended March 2026 as against Rs 1.59 crore during the previous quarter ended March 2025. Sales declined 29.91% to Rs 31.56 crore in the quarter ended March 2026 as against Rs 45.03 crore during the previous quarter ended March 2025.

For the full year,net profit rose 26.92% to Rs 1.98 crore in the year ended March 2026 as against Rs 1.56 crore during the previous year ended March 2025. Sales declined 29.53% to Rs 100.75 crore in the year ended March 2026 as against Rs 142.96 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales31.5645.03 -30 100.75142.96 -30
OPM %9.256.64 -5.584.09 -
PBDT3.012.91 3 5.355.04 6
PBT2.282.19 4 2.722.26 20
NP1.651.59 4 1.981.56 27